These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 26432332)
21. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance. Gong J; He L; Ma J; Zhang J; Wang L; Wang J J BUON; 2017; 22(2):454-461. PubMed ID: 28534369 [TBL] [Abstract][Full Text] [Related]
22. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer. Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600 [TBL] [Abstract][Full Text] [Related]
23. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC. Li YH; Xu CL; He CJ; Pu HH; Liu JL; Wang Y Mol Carcinog; 2020 Feb; 59(2):141-153. PubMed ID: 31749230 [TBL] [Abstract][Full Text] [Related]
24. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
25. MicroRNA-152 targets ADAM17 to suppress NSCLC progression. Su Y; Wang Y; Zhou H; Lei L; Xu L FEBS Lett; 2014 May; 588(10):1983-8. PubMed ID: 24780186 [TBL] [Abstract][Full Text] [Related]
26. Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1. Ye Z; Shen N; Weng Y; Li K; Hu L; Liao H; An J; Liu L; Lao S; Cai S Cancer Biol Ther; 2015; 16(7):1071-9. PubMed ID: 25961369 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑28 promotes the proliferation of non‑small‑cell lung cancer cells by targeting PTEN. Cui F; Zhou Q; Xiao K; Qian H Mol Med Rep; 2020 Jun; 21(6):2589-2596. PubMed ID: 32236614 [TBL] [Abstract][Full Text] [Related]
28. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis. An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989 [TBL] [Abstract][Full Text] [Related]
29. MiR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R. Wang X; Wang Y; Lan H; Li J Tumour Biol; 2014 Sep; 35(9):8765-70. PubMed ID: 24874051 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1. Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073 [TBL] [Abstract][Full Text] [Related]
31. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene. Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757 [TBL] [Abstract][Full Text] [Related]
32. MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis. Yang W; Bai J; Liu D; Wang S; Zhao N; Che R; Zhang H Gene; 2018 Mar; 647():13-20. PubMed ID: 29309884 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
34. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway. Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336 [TBL] [Abstract][Full Text] [Related]
35. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN. Zhu DY; Li XN; Qi Y; Liu DL; Yang Y; Zhao J; Zhang CY; Wu K; Zhao S Biomed Pharmacother; 2016 Jul; 81():79-85. PubMed ID: 27261580 [TBL] [Abstract][Full Text] [Related]
36. miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor. Yuan Y; Shen Y; Xue L; Fan H PLoS One; 2013; 8(9):e73604. PubMed ID: 24039995 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951 [TBL] [Abstract][Full Text] [Related]
38. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. Cai J; Fang L; Huang Y; Li R; Yuan J; Yang Y; Zhu X; Chen B; Wu J; Li M Cancer Res; 2013 Sep; 73(17):5402-15. PubMed ID: 23856247 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route. Sun B; Hu N; Cong D; Chen K; Li J Bioengineered; 2021 Dec; 12(1):3219-3228. PubMed ID: 34266345 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]